Molecular Diversity of VEGF-A as a Regulator of Its Biological Activity

References

• Anthony FW, Wheeler T, Elcock CL, Pickett M, Thomas EJ. Short report: identification of a specific pattern of vascular endothelial growth factor mRNA expression in human placenta and cultured placental fibroblasts. Placenta 1994; 15: 557–561
   PubMed Web of Science ®Google Scholar
• Autiero M, Waltenberger J, Communi D, Kranz A, Moons L, Lambrechts D, et al. Role of PlGF in the intra- and intermolecular cross-talk between the VEGF receptors Flt1 and Flk1. Nat Med 2003; 9: 936–943
   PubMed Web of Science ®Google Scholar
• Artac, RA, McFee, RM, Longfellow Smith, RA, Baltes-Breitwisch, MM, Clopton, DT, Cupp, AS. 2009. Neutralization of vascular endothelial growth factor inhibitory 1 isoforms is more effective than treatment with angiogenic isoforms in stimulating vascular development and follicle progression in the perinatal rat ovary. Biology of Reproduction. In press.
   Google Scholar
• Bachelder RE, Crago A, Chung J, Wendt MA, Shaw LM, Robinson G, et al. Vascular endothelial growth factor is an autocrine survival factor for neuropilin-expressing breast carcinoma cells. Cancer Res 2001; 61: 5736–5740
   PubMed Web of Science ®Google Scholar
• Baffert F, Le T, Sennino B, Thurston G, Kuo CJ, Hu-Lowe D, et al. Cellular changes in normal blood capillaries undergoing regression after inhibition of VEGF signaling. Am J Physiol Heart Circ Physiol 2006; 290: H547–H559
   PubMed Web of Science ®Google Scholar
• Bates DO. Molecular diversity of VEGF-A. J Vasc Res 2008; 45: 15
   Google Scholar
• Bates DO, Cui TG, Doughty JM, Winkler M, Sugiono M, Shields JD, et al. VEGF165b, an inhibitory splice variant of vascular endothelial growth factor, is downregulated in renal cell carcinoma. Cancer Res 2002; 62: 4123–4131
   PubMed Web of Science ®Google Scholar
• Bates DO, Curry FE. Vascular endothelial growth factor increases hydraulic conductivity of isolated perfused microvessels. Am J Physiol Heart Circ Physiol 1996; 271: H2520–H2528
   Google Scholar
• Bates DO, MacMillan PP, Manjaly JG, Qiu Y, Hudson SJ, Bevan HS, et al. The endogenous antiangiogenic family of splice variants of VEGF, VEGFxxxb, are downregulated in preeclamptic placentae at term. Clin Sci (Lond) 2006; 110: 575–585
   PubMedGoogle Scholar
• Bevan HS, van den Akker NHS, Qiu Y, Polman JA, Foster RR, Yem J, et al. The alternatively spliced antiangiogenic family of VEGF isoforms, VEGFxxxb, in human kidney development. Nephron Physiol 2008; 110: 57–67
   Google Scholar
• Bills, VL, Varet, J, Millar, AB, Harper, SJ, Soothil, PW, Bates, D. 2008. Failure to upregulate VEGF165b in maternal plasma is a first-trimester predictive marker for preeclampsia. Clin Sci (Lond), In press.
   Google Scholar
• Brown LF, Yeo KT, Berse B, Yeo TK, Senger DR, Dvorak HF, et al. Expression of vascular permeability factor (vascular endothelial growth factor) by epidermal keratinocytes during wound healing. J Exp Med 1992; 176: 1375–1379
   PubMed Web of Science ®Google Scholar
• Budge JR, Fryer JD, Bates DO. Intraperitoneal administration of recombinant human VEGF165b inhibits dissemination of metatatic melanoma cells in vivo. Microcirculation 2008; 17: 18–19
   Google Scholar
• Burchardt T, Burchardt M, Chen MW, Buttyan R, de la Taille A, Shabsigh A, et al. Expression of VEGF splice variants 144/145 and 205/206 in adult male tissues. IUBMB Life 1999; 48: 405–408
   PubMed Web of Science ®Google Scholar
• Burgess AW, Cho HS, Eigenbrot C, Ferguson KM, Garrett TP, Leahy DJ, et al. An open-and-shut case? Recent insights into the activation of EGF/ErbB receptors. Mol Cell 2003; 12: 541–552
   PubMed Web of Science ®Google Scholar
• Byzova TV, Goldman CK, Pampori N, Thomas KA, Bett A, Shattil SJ, et al. A mechanism for modulation of cellular responses to VEGF: activation of the integrins. Mol Cell 2000; 6: 851–860
   PubMed Web of Science ®Google Scholar
• Caceres JF, Kornblihtt AR. Alternative splicing: multiple control mechanisms and involvement in human disease. Trends Genet 2002; 18: 186–193
   PubMed Web of Science ®Google Scholar
• Carmeliet P. Developmental biology. Controlling the cellular brakes. Nature 1999; 401: 657–658
   Google Scholar
• Carmeliet P. Mechanisms of angiogenesis and arteriogenesis. Nat Med 2000; 6: 389–395
   PubMed Web of Science ®Google Scholar
• Carmeliet P. Angiogenesis in health and disease. Nat Med 2003; 9: 653–660
   PubMed Web of Science ®Google Scholar
• Catena R, Muniz-Medina V, Moralejo B, Javierre B, Best CJ, Emmert-Buck MR, et al. Increased expression of VEGF121/VEGF165–189 ratio results in a significant enhancement of human prostate tumor angiogenesis. Int J Cancer 2007; 120: 2096–2109
   Google Scholar
• Cebe Suarez S, Pieren M, Cariolato L, Arn S, Hoffmann U, Bogucki A, et al. A VEGF-A splice variant defective for heparan sulfate and neuropilin-1 binding shows attenuated signaling through VEGFR-2. Cell Mol Life Sci 2006; 63: 2067–2077
   PubMed Web of Science ®Google Scholar
• Cebe-Suarez S, Grunewald FS, Jaussi R, Li X, Claesson-Welsh L, Spillmann D, et al. Orf virus VEGF-E NZ2 promotes paracellular NRP-1/VEGFR-2 coreceptor assembly via the peptide RPPR. FASEB J 2008; 22: 3078–3086
   PubMed Web of Science ®Google Scholar
• Charnock-Jones DS, Sharkey AM, Rajput-Williams J, Burch D, Schofield JP, Fountain SA, et al. Identification and localization of alternately spliced mRNAs for vascular endothelial growth factor in human uterus and estrogen regulation in endometrial carcinoma cell lines. Biol Reprod 1993; 48: 1120–1128
   PubMed Web of Science ®Google Scholar
• Cheung CY, Singh M, Ebaugh MJ, Brace RA. Vascular endothelial growth factor gene expression in ovine placenta and fetal membranes. Am J Obstet Gynecol 1995; 173: 753–759
   PubMed Web of Science ®Google Scholar
• Cheung N, Wong MP, Yuen ST, Leung SY, Chung LP. Tissue-specific expression pattern of vascular endothelial growth factor isoforms in the malignant transformation of lung and colon. Hum Pathol 1998; 29: 910–914
   PubMedGoogle Scholar
• Claffey KP, Senger DR, Spiegelman BM. Structural requirements for dimerization, glycosylation, secretion, and biological function of VPF/VEGF. Biochim Biophys Acta Prot Struct Mol Enzymol 1995; 1246: 1–9
   Google Scholar
• Cohen GB, Ren R, Baltimore D. Modular binding domains in signal transduction proteins. Cell 1995; 80: 237–248
   PubMed Web of Science ®Google Scholar
• Cui TG, Foster RR, Saleem M, Mathieson PW, Gillatt DA, Bates DO, et al. Differentiated human podocytes endogenously express an inhibitory isoform of vascular endothelial growth factor (VEGF165b) mRNA and protein. Am J Physiol Renal Physiol 2004; 286: F767–F773
   PubMed Web of Science ®Google Scholar
• Cunningham SA, Arrate MP, Brock TA, Waxham MN. Interactions of FLT-1 and KDR with phospholipase C gamma: identification of the phosphotyrosine binding sites. Biochem Biophys Res Commun 1997; 240: 635–639
   PubMed Web of Science ®Google Scholar
• Cupp AS, Bott RC, Pohlmann R, Broeck RAT, Clopton DT. Regulation of vascular endothelial growth factor (VEGF-A) isoforms may be a mechanism to regulate sex-specific vascular development, cord formation, and follicle progression within developing gonads. J Vasc Res 2008; 44: 15
   Google Scholar
• de Vries C, Escobedo JA, Ueno H, Houck K, Ferrara N, Williams LT. The Fms-like tyrosine kinase, a receptor for vascular endothelial growth factor. Science 1992; 255: 989–991
   PubMed Web of Science ®Google Scholar
• Duh E, Aiello LP. Vascular endothelial growth factor and diabetes: the agonist versus antagonist paradox. Diabetes 1999; 48: 1899–1906
   PubMed Web of Science ®Google Scholar
• Eremina V, Sood M, Haigh J, Nagy A, Lajoie G, Ferrara N, et al. Glomerular-specific alterations of VEGF-A expression lead to distinct congenital and acquired renal diseases. J Clin Invest 2003; 111: 707–716
   PubMed Web of Science ®Google Scholar
• Ergorul C, Ray A, Huang W, Darland D, Luo ZK, Grosskreutz CL. Levels of vascular endothelial growth factor-A165b (VEGF-A165b are elevated in experimental glaucoma. Mol Vis 2008; 14: 1517–1524
   PubMedGoogle Scholar
• Faure C, Linossier MT, Malaval L, Lafage-Proust MH, Peyroche S, Vico L, et al. Mechanical signals modulated vascular endothelial growth factor-A (VEGF-A) alternative splicing in osteoblastic cells through actin polymerisation. Bone 2008; 42: 1092–1101
   PubMed Web of Science ®Google Scholar
• Fava RA, Olsen NJ, Spencer-Green G, Yeo KT, Yeo TK, Berse B, et al. Vascular permeability factor/endothelial growth factor (VPF/VEGF): accumulation and expression in human synovial fluids and rheumatoid synovial tissue. J Exp Med 1994; 180: 341–346
   PubMed Web of Science ®Google Scholar
• Favard C, Moukadiri H, Dorey C, Praloran V, Plouet J. Purification and biological properties of vasculotropin, a new angiogenic cytokine. Biol Cell 1991; 73: 1–6
   PubMed Web of Science ®Google Scholar
• Food and Drug Administration (FDA) . 2007. The FDA approves drugs for colorectal cancer, lung cancer. FDA Consum, 41.
   Google Scholar
• Ferrara N. Vascular endothelial growth factor: basic science and clinical progress. Endocr Rev 2004; 25: 581–611
   PubMed Web of Science ®Google Scholar
• Ferrara N, Bunting S. Vascular endothelial growth factor, a specific regulator of angiogenesis. Curr Opini Nephrol Hypertens 1996; 5: 35–44
   PubMedGoogle Scholar
• Ferrara N, Davis-Smyth T. The biology of vascular endothelial growth factor. Endocr Rev 1997; 18: 4–25
   PubMed Web of Science ®Google Scholar
• Ferrara N, Henzel WJ. Pituitary follicular cells secrete a novel heparin-binding growth factor specific for vascular endothelial cells. Biochem Biophys Res Commun 1989; 161: 851–858
   PubMed Web of Science ®Google Scholar
• Folkman J. Role of angiogenesis in tumor growth and metastasis. Semin Oncol 2002; 29: 15–18
   PubMed Web of Science ®Google Scholar
• Folkman J, Shing Y. Angiogenesis. J Biol Chem 1992; 267: 10931–10934
   PubMed Web of Science ®Google Scholar
• Foster RR, Saleem MA, Mathieson PW, Bates DO, Harper SJ. Vascular endothelial growth factor and nephrin interact and reduce apoptosis in human podocytes. Am J Physiol Renal Physiol 2005; 288: F48–F57
   PubMed Web of Science ®Google Scholar
• Freitas-Andrade M, Carmeliet P, Stanimirovic DB, Moreno M. VEGFR-2-mediated increased proliferation and survival in response to oxygen and glucose deprivation in PlGF knockout astrocytes. J Neurochem 2008; 107: 756–767
   Google Scholar
• Fuh G, Li B, Crowley C, Cunningham B, Wells JA. Requirements for binding and signaling of the kinase domain receptor for vascular endothelial growth factor. J Biol Chem 1998; 273: 11197–11204
   PubMed Web of Science ®Google Scholar
• Gasparini G. Prognostic value of vascular endothelial growth factor in breast cancer. Oncologist 2000; 5(Suppl 1)37–44
   PubMedGoogle Scholar
• Gerber HP, Dixit V, Ferrara N. Vascular endothelial growth factor induces expression of the antiapoptotic proteins Bcl-2 and A1 in vascular endothelial cells. J Biol Chem 1998; 273: 13313–13316
   PubMed Web of Science ®Google Scholar
• Gerhardt H, Golding M, Fruttiger M, Ruhrberg C, Lundkvist A, Abramsson A, et al. VEGF guides angiogenic sprouting utilizing endothelial tip cell filopodia. J Cell Biol 2003; 161: 1163–1177
   PubMed Web of Science ®Google Scholar
• Giatromanolaki A, Koukourakis MI, Sivridis E, Turley H, Talks K, Pezzella F, et al. Relation of hypoxia inducible factor 1 alpha and 2 alpha in operable non-small-cell lung cancer to angiogenic/molecular profile of tumours and survival. Br J Cancer 2001; 85: 881–890
   PubMed Web of Science ®Google Scholar
• Gille H, Kowalski J, Li B, LeCouter J, Moffat B, Zioncheck TF, et al. Analysis of biological effects and signaling properties of Flt-1 (VEGFR-1) and KDR (VEGFR-2). A reassessment using novel receptor-specific vascular endothelial growth factor mutants. J Biol Chem 2001; 276: 3222–3230
   PubMed Web of Science ®Google Scholar
• Gitay-Goren H, Soker S, Vlodavsky I, Neufeld G. The binding of vascular endothelial growth factor to its receptors is dependent on cell surface–associated heparin-like molecules. J Biol Chem 1992; 267: 6093–6098
   PubMed Web of Science ®Google Scholar
• Gluzman-Poltorak Z, Cohen T, Herzog Y, Neufeld G. Neuropilin-2 is a receptor for the vascular endothelial growth factor (VEGF) forms VEGF-145 and VEGF-165. J Biol Chem 2000; 275: 29922
   Web of Science ®Google Scholar
• Gospodarowicz D, Lau K. Pituitary follicular cells secrete both vascular endothelial growth factor and follistatin. Biochem Biophys Res Commun 1989; 165: 292–298
   PubMed Web of Science ®Google Scholar
• Gragoudas ES, Adamis AP, Cunningham ET, Jr, Feinsod M, Guyer DR. Pegaptanib for neovascular age-related macular degeneration. NEJM 2004; 351: 2805–2816
   PubMed Web of Science ®Google Scholar
• Grutzkau A, Kruger-Krasagakes S, Baumeister H, Schwarz C, Kogel H, Welker P, et al. Synthesis, storage, and release of vascular endothelial growth factor/vascular permeability factor (VEGF/VPF) by human mast cells: implications for the biological significance of VEGF-206. Mol Biol Cell 1998; 9: 875–884
   PubMed Web of Science ®Google Scholar
• Guerrin M, Moukadiri H, Chollet P, Moro F, Dutt K, Malecaze F, et al. Vasculotropin/vascular endothelial growth factor is an autocrine growth factor for human retinal pigment epithelial cells cultured in vitro. J Cell Physiol 1995; 164: 385–394
   PubMed Web of Science ®Google Scholar
• Hanahan D, Folkman J. Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis. Cell 1996; 86: 353–364
   PubMed Web of Science ®Google Scholar
• Herve MA, Buteau-Lozano H, Mourah S, Calvo F, Perrot-Applanat M. VEGF-189 stimulates endothelial cells proliferation and migration in vitro and upregulates the expression of Flk-1/KDR mRNA. Exp Cell Res 2005; 309: 24–31
   Google Scholar
• Herve MA, Buteau-Lozano H, Vassy R, Bieche I, Velasco G, Pla M, et al. Overexpression of vascular endothelial growth factor 189 in breast cancer cells leads to delayed tumor uptake with dilated intratumoral vessels. Am J Pathol 2008; 172: 167–178
   PubMed Web of Science ®Google Scholar
• Hofstaetter JG, Saad FA, Samuel RE, Wunderlich L, Choi YH, Glimcher MJ. Differential expression of VEGF isoforms and receptors in knee joint menisci under systemic hypoxia. Biochem Biophys Res Commun 2004; 324: 667–672
   Google Scholar
• Hofstaetter JG, Saad FA, Sunk IG, Bobacz K, Friehs I, Glimcher MJ. Age-dependent expression of VEGF isoforms and receptors in the rabbit anterior cruciate ligament. Biochim Biophys Acta 2007; 1770: 997–1002
   Google Scholar
• Houck KA, Ferrara N, Winer J, Cachianes G, Li B, Leung DW. The vascular endothelial growth factor family: identification of a fourth molecular species and characterization of alternative splicing of RNA. Mol Endocrinol 1991; 5: 1806–1814
   PubMed Web of Science ®Google Scholar
• Houck KA, Leung DW, Rowland AM, Winer J, Ferrara N. Dual regulation of vascular endothelial growth factor bioavailability by genetic and proteolytic mechanisms. J Biol Chem 1992; 267: 26031–26037
   PubMed Web of Science ®Google Scholar
• Huang K, Andersson C, Roomans GM, Ito N, Claesson-Welsh L. Signaling properties of VEGF receptor-1 and -2 homo- and heterodimers. Int J Biochem Cell Biol 2001; 33: 315–324
   PubMed Web of Science ®Google Scholar
• Hubbard SR. Structural analysis of receptor tyrosine kinases. Prog Biophys Mol Biol 1999; 71: 343–358
   PubMed Web of Science ®Google Scholar
• Hutchings H, Ortega N, Plouet J. Extracellular matrix–bound vascular endothelial growth factor promotes endothelial cell adhesion, migration, and survival through integrin ligation. FASEB J 2003; 17: 1520–1522
   PubMed Web of Science ®Google Scholar
• Ito N, Huang K, Claesson-Welsh L. Signal transduction by VEGF receptor-1 wild type and mutant proteins. Cell Signal 2001; 13: 849–854
   PubMed Web of Science ®Google Scholar
• Ito N, Wernstedt C, Engstrom U, Claesson-Welsh L. Identification of vascular endothelial growth factor receptor-1 tyrosine phosphorylation sites and binding of SH2 domain-containing molecules. J Biol Chem 1998; 273: 23410–23418
   PubMed Web of Science ®Google Scholar
• Jacobsen J, Grankvist K, Rasmuson T, Ljungberg B. Different isoform patterns for vascular endothelial growth factor between clear cell and papillary renal cell carcinoma. BJU Int 2006; 97: 1102–1108
   PubMed Web of Science ®Google Scholar
• Jia H, Bagherzadeh A, Hartzoulakis B, Jarvis A, Lohr M, Shaikh S, et al. Characterization of a bicyclic peptide neuropilin-1 (NP-1) antagonist (EG3287) reveals importance of vascular endothelial growth factor exon 8 for NP-1 binding and role of NP-1 in KDR signaling. J Biol Chem 2006; 281: 13493–13502
   PubMed Web of Science ®Google Scholar
• Jingjing L, Srinivasan B, Roque RS. Ectodomain shedding of VEGF-183, a novel isoform of vascular endothelial growth factor, promotes its mitogenic activity in vitro. Angiogenesis 2001; 4: 103–112
   Google Scholar
• Jingjing L, Xue Y, Agarwal N, Roque RS. Human Müller cells express VEGF-183, a novel spliced variant of vascular endothelial growth factor. Invest Ophthalmol Vis Sci 1999; 40: 752–759
   PubMed Web of Science ®Google Scholar
• Kanno S, Oda N, Abe M, Terai Y, Ito M, Shitara K, et al. Roles of two VEGF receptors, Flt-1 and KDR, in the signal transduction of VEGF effects in human vascular endothelial cells. Oncogene 2000; 19: 2138–2146
   PubMed Web of Science ®Google Scholar
• Katoh O, Tauchi H, Kawaishi K, Kimura A, Satow Y. Expression of the vascular endothelial growth factor (VEGF) receptor gene, KDR, in hematopoietic cells and inhibitory effect of VEGF on apoptotic cell death caused by ionizing radiation. Cancer Res 1995; 55: 5687–5692
   PubMed Web of Science ®Google Scholar
• Kawai H, Minamiya Y, Ito M, Saito H, Ogawa J. VEGF-121 promotes lymphangiogenesis in the sentinel lymph nodes of non-small-cell lung carcinoma patients. Lung Cancer 2008; 59: 41–47
   PubMed Web of Science ®Google Scholar
• Kawamura H, Li X, Goishi K, van Meeteren LA, Jakobsson L, Cebe-Suarez S, et al. Neuropilin-1 in regulation of VEGF-induced activation of p38MAPK and endothelial cell organization. Blood 2008; 112: 3638–3649
   PubMed Web of Science ®Google Scholar
• Kawamura H, Li X, Harper SJ, Bates DO, Claesson-Welsh L. Vascular endothelial growth factor (VEGF)-A165b is a weak in vitro agonist for VEGF receptor-2 due to lack of coreceptor binding and deficient regulation of kinase activity. Cancer Res 2008; 68: 4683–4692
   PubMed Web of Science ®Google Scholar
• Keck PJ, Hauser SD, Krivi G, Sanzo K, Warren T, Feder J, et al. Vascular permeability factor, an endothelial cell mitogen related to PDGF. Science 1989; 246: 1309–1312
   PubMed Web of Science ®Google Scholar
• Keck RG, Berleau L, Harris R, Keyt BA. Disulfide structure of the heparin binding domain in vascular endothelial growth factor: characterization of posttranslational modifications in VEGF. Arch Biochem Biophys 1997; 344: 103–113
   Google Scholar
• Kendall RL, Rutledge RZ, Mao X, Tebben AJ, Hungate RW, Thomas KA. Vascular endothelial growth factor receptor KDR tyrosine kinase activity is increased by autophosphorylation of two activation loop tyrosine residues. J Biol Chem 1999; 274: 6453–6460
   PubMed Web of Science ®Google Scholar
• Kerbel RS. Tumor angiogenesis. NEJM 2008; 358: 2039–2049
   PubMed Web of Science ®Google Scholar
• Keyt BA, Berleau LT, Nguyen HV, Chen H, Heinsohn H, Vandlen R, et al. The carboxyl-terminal domain (111–165) of vascular endothelial growth factor is critical for its mitogenic potency. J Biol Chem 1996; 271: 7788–7795
   PubMed Web of Science ®Google Scholar
• Kondo S, Matsumoto T, Yokoyama Y, Ohmori I, Suzuki H. The shortest isoform of human vascular endothelial growth factor/vascular permeability factor (VEGF/VPF121) produced by Saccharomyces cerevisiae promotes both angiogenesis and vascular permeability. Biochim Biophys Acta 1995; 1243: 195–202
   Google Scholar
• Konopatskaya O, Churchill AJ, Harper SJ, Bates DO, Gardiner TA. VEGF165b, an endogenous C-terminal splice variant of VEGF, inhibits retinal neovascularization in mice. Mol Vis 2006; 12: 626–632
   PubMed Web of Science ®Google Scholar
• Krussel JS, Bielfeld P, Polan ML, Simon C. Regulation of embryonic implantation. Eur J Obstet Gynecol Reprod Biol 2003; 110(Suppl 1)S2–S9
   Google Scholar
• Ku DD, Zaleski JK, Liu S, Brock TA. Vascular endothelial growth factor induces EDRF-dependent relaxation in coronary arteries. Am J Physiol Heart Circ Physiol 1993; 265: H586–H592
   PubMed Web of Science ®Google Scholar
• Lambrechts D, Storkebaum E, Morimoto M, Del-Favero J, Desmet F, Marklund SL, et al. VEGF is a modifier of amyotrophic lateral sclerosis in mice and humans and protects motoneurons against ischemic death. Nat Genet 2003; 34: 383–394
   PubMed Web of Science ®Google Scholar
• Lamoreaux WJ, Fitzgerald M, Reiner A, Hasty KA, Charles ST. Vascular endothelial growth factor increases release of gelatinase A and decreases release of tissue inhibitor of metalloproteinases by microvascular endothelial cells in vitro. Microvasc Res 1998; 55: 29–42
   PubMed Web of Science ®Google Scholar
• Landgren E, Schiller P, Cao Y, Claesson-Welsh L. Placenta growth factor stimulates MAP kinase and mitogenicity but not phospholipase C-gamma and migration of endothelial cells expressing Flt 1. Oncogene 1998; 16: 359–367
   PubMed Web of Science ®Google Scholar
• Lange T, Guttmann-Raviv N, Baruch L, Machluf M, Neufeld G. VEGF-162, a new heparin-binding vascular endothelial growth factor splice form that is expressed in transformed human cells. J Biol Chem 2003; 278: 17164–17169
   PubMed Web of Science ®Google Scholar
• Leach L, Reeve KS, Garrioch MA, Bates DO. Effects of gestational diabetes (GDM) on vascular integrity of the human placenta: the role of VEGF165b. Microcirculation 2006; 13: 526
   Google Scholar
• Lee S, Chen TT, Barber CL, Jordan MC, Murdock J, Desai S, et al. Autocrine VEGF signaling is required for vascular homeostasis. Cell 2007; 130: 691–703
   PubMed Web of Science ®Google Scholar
• Lei J, Jiang A, Pei D. Identification and characterization of a new splicing variant of vascular endothelial growth factor: VEGF-183. Biochim Biophys Acta 1998; 1443: 400–406
   PubMed Web of Science ®Google Scholar
• Leung DW, Cachianes G, Kuang WJ, Goeddel DV, Ferrara N. Vascular endothelial growth factor is a secreted angiogenic mitogen. Science 1989; 246: 1306–1309
   PubMed Web of Science ®Google Scholar
• Li Q, Xu B, Fu L, Hao XS. Correlation of four vascular specific growth factors with carcinogenesis and portal vein tumor thrombus formation in human hepatocellular carcinoma. J Exp Clin Cancer Res 2006; 25: 403–409
   Google Scholar
• Li Z, Zhang Y, Ying Ma J, Kapoun AM, Shao Q, Kerr I, Lam A, et al. Recombinant vascular endothelial growth factor 121 attenuates hypertension and improves kidney damage in a rat model of preeclampsia. Hypertension 2007; 50: 686–692
   PubMed Web of Science ®Google Scholar
• Lowe J, Araujo J, Yang J, Reich M, Oldendorp A, Shiu V, et al. Ranibizumab inhibits multiple forms of biologically active vascular endothelial growth factor in vitro and in vivo. Exp Eye Res 2007; 85: 425–430
   PubMed Web of Science ®Google Scholar
• Madri JA, Graesser D, Haas T. The roles of adhesion molecules and proteinases in lymphocyte transendothelial migration. Biochem Cell Biol 1996; 74: 749–757
   PubMed Web of Science ®Google Scholar
• Maes C, Stockmans I, Moermans K, Van Looveren R, Smets N, Carmeliet P, et al. Soluble VEGF isoforms are essential for establishing epiphyseal vascularization and regulating chondrocyte development and survival. J Clin Invest 2004; 113: 188–199
   PubMed Web of Science ®Google Scholar
• McCarthy M. Antiangiogenesis drug promising for metastatic colorectal cancer. Lancet 2003; 361: 1959
   PubMed Web of Science ®Google Scholar
• McColl BK, Stacker SA, Achen MG. Molecular regulation of the VEGF family—inducers of angiogenesis and lymphangiogenesis. APMIS 2004; 112: 463–380
   PubMed Web of Science ®Google Scholar
• Mesri EA, Federoff HJ, Brownlee M. Expression of vascular endothelial growth factor from a defective herpes simplex virus type 1 amplicon vector induces angiogenesis in mice. Circ Res 1995; 76: 161–167
   PubMed Web of Science ®Google Scholar
• Miller-Kasprzak E, Jagodzinski PP. 5-aza-2-deoxycytidine increases the expression of antiangiogenic vascular endothelial growth factor 189b variant in human lung microvascular endothelial cells. Biomed Pharmacother 2008; 62: 158–163
   Google Scholar
• Mineur P, Colige AC, Deroanne CF, Dubail J, Kesteloot F, Habraken Y, et al. Newly identified biologically active and proteolysis-resistant VEGF-A isoform VEGF-111 is induced by genotoxic agents. J Cell Biol 2007; 179: 1261–1273
   Google Scholar
• Mitchell CA, Rutland CS, Walker M, Nasir M, Foss AJ, Stewart C, et al. Unique vascular phenotypes following overexpression of individual VEGF-A isoforms from the developing lens. Angiogenesis 2006; 9: 209–224
   PubMedGoogle Scholar
• Nishi M, Abe Y, Tomii Y, Tsukamoto H, Kijima H, Yamazaki H, et al. Cell-binding isoforms of vascular endothelial growth factor-A (VEGF-189) contribute to blood flow–distant metastasis of pulmonary adenocarcinoma. Int J Oncol 2005; 26: 1517–1524
   Google Scholar
• Nowak DG, Woolard J, Amin EM, Konopatskaya O, Saleem MA, Churchill AJ, et al. Expression of pro- and antiangiogenic isoforms of VEGF is differentially regulated by splicing and growth factors. J Cell Sci 2008; 121: 3487–3495
   PubMed Web of Science ®Google Scholar
• Oshika Y, Nakamura M, Tokunaga T, Ozeki Y, Fukushima Y, Hatanaka H, et al. Expression of cell-associated isoform of vascular endothelial growth factor 189 and its prognostic relevance in non-small-cell lung cancer. Int J Oncol 1998; 12: 541–544
   Google Scholar
• Pan Q, Chathery Y, Wu Y, Rathore N, Tong RK, Peale F, et al. Neuropilin-1 binds to VEGF-121 and regulates endothelial cell migration and sprouting. J Biol Chem 2007; 282: 24049–24056
   PubMed Web of Science ®Google Scholar
• Park JE, Keller GA, Ferrara N. The vascular endothelial growth factor (VEGF) isoforms: differential deposition into the subepithelial extracellular matrix and bioactivity of extracellular matrix–bound VEGF. Mol Biol Cell 1993; 4: 1317–1326
   PubMed Web of Science ®Google Scholar
• Pepper MS, Ferrara N, Orci L, Montesano R. Potent synergism between vascular endothelial growth factor and basic fibroblast growth factor in the induction of angiogenesis in vitro. Biochem Biophys Res Commun 1992; 189: 824–831
   PubMed Web of Science ®Google Scholar
• Pepper MS, Wasi S, Ferrara N, Orci L, Montesano R. In vitro angiogenic and proteolytic properties of bovine lymphatic endothelial cells. Exp Cell Res 1994; 210: 298–305
   PubMed Web of Science ®Google Scholar
• Perrin RM, Konopatskaya O, Qiu Y, Harper S, Bates DO, Churchill AJ. Diabetic retinopathy is associated with a switch in splicing from anti- to proangiogenic isoforms of vascular endothelial growth factor. Diabetologia 2005; 48: 2422–2427
   PubMed Web of Science ®Google Scholar
• Peters KG, De Vries C, Williams LT. Vascular endothelial growth factor receptor expression during embryogenesis and tissue repair suggests a role in endothelial differentiation and blood vessel growth. Proc Natl Acad Sci U S A 1993; 90: 8915–8919
   PubMed Web of Science ®Google Scholar
• Phillips GD, Stone AM, Jones BD, Schultz JC, Whitehead RA, Knighton DR. Vascular endothelial growth factor (rhVEGF-165) stimulates direct angiogenesis in the rabbit cornea. In Vivo 1994; 8: 961–965
   PubMedGoogle Scholar
• Pidgeon GP, Barr MP, Harmey JH, Foley DA, Bouchier-Hayes DJ. Vascular endothelial growth factor (VEGF) upregulates Bcl-2 and inhibits apoptosis in human and murine mammary adenocarcinoma cells. Br J Cancer 2001; 85: 273–278
   PubMed Web of Science ®Google Scholar
• Poltorak Z, Cohen T, Sivan R, Kandelis Y, Spira G, Vlodavsky I, et al. VEGF-145, a secreted vascular endothelial growth factor isoform that binds to extracellular matrix. J Biol Chem 1997; 272: 7151–7158
   PubMed Web of Science ®Google Scholar
• Praloran V, Mirshahi S, Favard C, Moukadiri H, Plouet J. Mitogenic activity of vasculotropin for peripheral human lymphocytes]. C R Acad Sci III 1991; 313: 21–26
   Google Scholar
• Pritchard-Jones RO, Dunn DB, Qiu Y, Varey AH, Orlando A, Rigby H, et al. Expression of VEGF(xxx)b, the inhibitory isoforms of VEGF, in malignant melanoma. Br J Cancer 2007; 97: 223–230
   PubMedGoogle Scholar
• Qi JH, Claesson-Welsh L. VEGF-induced activation of phosphoinositide 3-kinase is dependent on focal adhesion kinase. Exp Cell Res 2001; 263: 173–182
   PubMed Web of Science ®Google Scholar
• Qi JH, Matsumoto T, Huang K, Olausson K, Christofferson R, Claesson-Welsh L. Phosphoinositide 3 kinase is critical for survival, mitogenesis, and migration but not for differentiation of endothelial cells. Angiogenesis 1999; 3: 371–380
   Google Scholar
• Qiu Y, Bevan H, Weeraperuma S, Wratting D, Murphy D, Neal CR, et al. Mammary alveolar development during lactation is inhibited by the endogenous antiangiogenic growth factor isoform, VEGF165b. Faseb J. 2008; 22: 1104–1112
   Google Scholar
• Quinn TP, Peters KG, De Vries C, Ferrara N, Williams LT. Fetal liver kinase 1 is a receptor for vascular endothelial growth factor and is selectively expressed in vascular endothelium. Proc Natl Acad Sci U S A 1993; 90: 7533–7537
   PubMed Web of Science ®Google Scholar
• Redmer DA, Reynolds LP. Angiogenesis in the ovary. Rev Reprod 1996; 1: 182–192
   PubMedGoogle Scholar
• Regina S, Rollin J, Blechet C, Iochmann S, Reverdiau P, Gruel Y. Tissue factor expression in non-small-cell lung cancer: relationship with vascular endothelial growth factor expression, microvascular density, and K-ras mutation. J Thorac Oncol 2008; 3: 689–697
   Google Scholar
• Rennel ES, H-Zadeh MA, Wheatley E, Schuler Y, Kelly SP, Cebe Suarez S, et al. Recombinant human VEGF165b protein is an effective anticancer agent in mice. Eur J Cancer 2008; 44: 1883–1894
   PubMed Web of Science ®Google Scholar
• Rennel ES, Hamdollah-Zadeh MA, Wheatley ER, Magnussen A, Schuler Y, Kelly SP, et al. Recombinant human VEGF165b protein is an effective anticancer agent in mice. Eur J Cancer 2008; 44: 1883–1894
   PubMed Web of Science ®Google Scholar
• Rennel ES, Varey AH, Churchill AJ, Harper SJ, Bates DO. VEGF121b is antiangiogenic in cancer and eye disease. Microcirculation 2008; 15: 638–639
   Google Scholar
• Reynolds LP, Redmer DA. Expression of the angiogenic factors, basic fibroblast growth factor, and vascular endothelial growth factor, in the ovary. J Anim Sci 1998; 76: 1671–1681
   Google Scholar
• Ribeiro LA, Bacci ML, Seren E, Tamanini C, Forni M. Characterization and differential expression of vascular endothelial growth factor isoforms and receptors in swine corpus luteum throughout estrous cycle. Mol Reprod Dev 2007; 74: 163–171
   Google Scholar
• Risau W, Flamme I. Vasculogenesis. Annu Rev Cell Dev Biol 1995; 11: 73–91
   PubMed Web of Science ®Google Scholar
• Rosenfeld PJ, Brown DM, Heier JS, Boyer DS, Kaiser PK, Chung CY, et al. Ranibizumab for neovascular age-related macular degeneration. NEJM 2006; 355: 1419–1431
   PubMed Web of Science ®Google Scholar
• Ruch C, Skiniotis G, Steinmetz MO, Walz T, Ballmer-Hofer K. Structure of a VEGF-VEGF receptor complex determined by electron microscopy. Nat Struct Mol Biol 2007; 14: 249–250
   PubMedGoogle Scholar
• Ruhrberg C, Gerhardt H, Golding M, Watson R, Ioannidou S, Fujisawa H, et al. Spatially restricted patterning cues provided by heparin-binding VEGF-A control blood vessel branching morphogenesis. Genes Dev 2002; 16: 2684–2698
   PubMed Web of Science ®Google Scholar
• Salven P, Perhoniemi V, Tykka H, Maenpaa H, Joensuu H. Serum VEGF levels in women with a benign breast tumor or breast cancer. Breast Cancer Res Treat 1999; 53: 161–166
   PubMed Web of Science ®Google Scholar
• Sawano A, Takahashi T, Yamaguchi S, Shibuya M. The phosphorylated 1169-tyrosine containing region of Flt-1 kinase (VEGFR-1) is a major binding site for PLC-gamma. Biochem Biophys Res Commun 1997; 238: 487–491
   PubMed Web of Science ®Google Scholar
• Schlessinger J. New roles for Src kinases in control of cell survival and angiogenesis. Cell 2000; 100: 293–296
   PubMed Web of Science ®Google Scholar
• Schlessinger J, Lemmon MA. SH2 and PTB domains in tyrosine kinase signaling. Sci STKE. :R 2003; 2003: E12
   Google Scholar
• Schumacher VA, Jeruschke S, Eitner F, Becker JU, Pitschke G, Ince Y, et al. Impaired glomerular maturation and lack of VEGF165b in Denys-Drash syndrome. J Am Soc Nephrol 2007; 18: 719–729
   Google Scholar
• Sciota F, Lucas J, Thomas R, Leach L. Insulin perfusion decreases expression of the splice variant VEGF165b in large vessels of the human term chorionic stem villi but not in microvessels. J Vasc Res 2008; 44: 87
   Google Scholar
• Senger DR, Perruzzi CA, Feder J, Dvorak HF. A highly conserved vascular permeability factor secreted by a variety of human and rodent tumor cell lines. Cancer Res 1986; 46: 5629–5632
   PubMed Web of Science ®Google Scholar
• Shibuya M. Role of VEGF-FLT receptor system in normal and tumor angiogenesis. Adv Cancer Res 1995; 67: 281–316
   PubMed Web of Science ®Google Scholar
• Shinkai A, Ito M, Anazawa H, Yamaguchi S, Shitara K, Shibuya M. Mapping of the sites involved in ligand association and dissociation at the extracellular domain of the kinase insert domain-containing receptor for vascular endothelial growth factor. J Biol Chem 1998; 273: 31283–31288
   PubMed Web of Science ®Google Scholar
• Shraga-Heled N, Kessler O, Prahst C, Kroll J, Augustin H, Neufeld G. Neuropilin-1 and neuropilin-2 enhance VEGF-121 stimulated signal transduction by the VEGFR-2 receptor. FASEB J 2007; 21: 915–926
   Google Scholar
• Sipos B, Weber D, Ungefroren H, Kalthoff H, Zuhlsdorff A, Luther C, et al. Vascular endothelial growth factor mediated angiogenic potential of pancreatic ductal carcinomas enhanced by hypoxia: an in vitro and in vivo study. Int J Cancer. 2002; 102: 592–600
   Google Scholar
• Soker S, Takashima S, Miao HQ, Neufeld G, Klagsbrun M. Neuropilin-1 is expressed by endothelial and tumor cells as an isoform-specific receptor for vascular endothelial growth factor. Cell 1998; 92: 735–745
   PubMed Web of Science ®Google Scholar
• Sondell M, Lundborg G, Kanje M. Vascular endothelial growth factor has neurotrophic activity and stimulates axonal outgrowth, enhancing cell survival and Schwann cell proliferation in the peripheral nervous system. J Neurosci 1999; 19: 5731–5740
   PubMed Web of Science ®Google Scholar
• Sowter HM, Corps AN, Evans AL, Clark DE, Charnock-Jones DS, Smith SK. Expression and localization of the vascular endothelial growth factor family in ovarian epithelial tumors. Lab Invest 1997; 77: 607–614
   PubMed Web of Science ®Google Scholar
• Springer ML, Banfi A, Ye J, von Degenfeld G, Kraft PE, Saini SA, et al. Localization of vascular response to VEGF is not dependent on heparin binding. FASEB J 2007; 21: 2074–2085
   PubMed Web of Science ®Google Scholar
• Stalmans I, Ng YS, Rohan R, Fruttiger M, Bouche A, Yuce A, et al. Arteriolar and venular patterning in retinas of mice selectively expressing VEGF isoforms. J Clin Invest 2002; 109: 327–336
   PubMed Web of Science ®Google Scholar
• Starita C, Patel M, Katz B, Adamis AP. Vascular endothelial growth factor and the potential therapeutic use of pegaptanib (Macugen) in diabetic retinopathy. Dev Ophthalmol 2007; 39: 122–148
   PubMedGoogle Scholar
• Takahashi H, Shibuya M. The vascular endothelial growth factor (VEGF)/VEGF receptor system and its role under physiological and pathological conditions. Clin Sci (Lond) 2005; 109: 227–241
   PubMed Web of Science ®Google Scholar
• Takahashi T, Ueno H, Shibuya M. VEGF activates protein kinase C–dependent, but Ras-independent Raf-MEK-MAP kinase pathway for DNA synthesis in primary endothelial cells. Oncogene 1999; 18: 2221–2230
   PubMed Web of Science ®Google Scholar
• Tamura M, Ohta Y, Kajita T, Kimura K, Go T, Oda M, et al. Plasma VEGF concentration can predict the tumor angiogenic capacity in non-small-cell lung cancer. Oncol Rep 2001; 8: 1097–1102
   PubMedGoogle Scholar
• Tas F, Duranyildiz D, Oguz H, Camlica H, Yasasever V, Topuz E. Serum vascular endothelial growth factor (VEGF) and Bcl-2 levels in advanced-stage non-small-cell lung cancer. Cancer Invest 2006; 24: 576–580
   PubMed Web of Science ®Google Scholar
• Terman BI, Carrion ME, Kovacs E, Rasmussen BA, Eddy RL, Shows TB. Identification of a new endothelial cell growth factor receptor tyrosine kinase. Oncogene 1991; 6: 1677–1683
   PubMed Web of Science ®Google Scholar
• Terman BI, Dougher-Vermazen M, Carrion ME, Dimitrov D, Armellino DC, Gospodarowicz D, et al. Identification of the KDR tyrosine kinase as a receptor for vascular endothelial cell growth factor. Biochem Biophys Res Commun 1992; 187: 1579–1586
   PubMed Web of Science ®Google Scholar
• Thakker GD, Hajjar DP, Muller WA, Rosengart TK. The role of phosphatidylinositol 3-kinase in vascular endothelial growth factor signaling. J Biol Chem 1999; 274: 10002–10007
   PubMed Web of Science ®Google Scholar
• Tomisawa M, Tokunaga T, Oshika Y, Tsuchida T, Fukushima Y, Sato H, et al. Expression pattern of vascular endothelial growth factor isoform is closely correlated with tumour stage and vascularisation in renal cell carcinoma. Eur J Cancer 1999; 35: 133–137
   PubMed Web of Science ®Google Scholar
• Tran J, Rak J, Sheehan C, Saibil SD, LaCasse E, Korneluk RG, et al. Marked induction of the IAP family antiapoptotic proteins survivin and XIAP by VEGF in vascular endothelial cells. Biochem Biophys Res Commun 1999; 264: 781–788
   PubMed Web of Science ®Google Scholar
• Uthoff SM, Duchrow M, Schmidt MH, Broll R, Bruch HP, Strik MW, et al. VEGF isoforms and mutations in human colorectal cancer. Int J Cancer 2002; 101: 32–36
   PubMed Web of Science ®Google Scholar
• Varey AH, Rennel ES, Qiu Y, Bevan HS, Perrin RM, Raffy S, et al. VEGF165b, an antiangiogenic VEGF-A isoform, binds and inhibits bevacizumab treatment in experimental colorectal carcinoma: balance of pro- and antiangiogenic VEGF-A isoforms has implications for therapy. Br J Cancer 2008; 98: 1366–1379
   PubMed Web of Science ®Google Scholar
• Venables JP. Aberrant and alternative splicing in cancer. Cancer Res 2004; 64: 7647–7654
   PubMed Web of Science ®Google Scholar
• Venables JP. Unbalanced alternative splicing and its significance in cancer. Bioessays 2006; 28: 378–386
   PubMedGoogle Scholar
• Vincenti V, Cassano C, Rocchi M, Persico G. Assignment of the vascular endothelial growth factor gene to human chromosome 6p21.3. Circulation 1996; 93: 1493–1495
   PubMed Web of Science ®Google Scholar
• Waltenberger J, Claesson-Welsh L, Siegbahn A, Shibuya M, Heldin CH. Different signal transduction properties of KDR and Flt1, two receptors for vascular endothelial growth factor. J Biol Chem 1994; 269: 26988–26995
   PubMed Web of Science ®Google Scholar
• Whittle C, Gillespie K, Harrison R, Mathieson PW, Harper SJ. Heterogeneous vascular endothelial growth factor (VEGF) isoform mRNA and receptor mRNA expression in human glomeruli, and the identification of VEGF-148 mRNA, a novel truncated splice variant. Clin Sci (Colch) 1999; 97: 303–312
   Google Scholar
• Witmer AN, Vrensen GF, Van Noorden CJ, Schlingemann RO. Vascular endothelial growth factors and angiogenesis in eye disease. Prog Retin Eye Res 2003; 22: 1–29
   PubMed Web of Science ®Google Scholar
• Woolard J., Wang WY, Bevan HS, Qiu Y, Morbidelli L, Pritchard-Jones RO, et al. VEGF165b, an inhibitory vascular endothelial growth factor splice variant: mechanism of action, in vivo effect on angiogenesis and endogenous protein expression. Cancer Res 2004; 64: 7822–7835
   PubMed Web of Science ®Google Scholar
• Wylegala E, Teper SJ. [VEGF in age-related macular degeneration. Part II. VEGF inhibitors use in age-related macular degeneration treatment]. Klin Oczna 2007; 109: 97–100
   Google Scholar
• Yang CC, Chu KC, Yeh WM. Expression of vascular endothelial growth factor in renal cell carcinoma is correlated with cancer advancement. J Clin Lab Anal 2003; 17: 85–89
   PubMed Web of Science ®Google Scholar
• Yuan A, Yu CJ, Kuo SH, Chen WJ, Lin FY, Luh KT, et al. Vascular endothelial growth factor 189 mRNA isoform expression specifically correlates with tumor angiogenesis, patient survival, and postoperative relapse in non-small-cell lung cancer. J Clin Oncol 2001; 19: 432–441
   PubMed Web of Science ®Google Scholar
• Zacchigna S, Pattarini L, Zentilin L, Moimas S, Carrer A, Sinigaglia M, et al. Bone marrow cells recruited through the neuropilin-1 receptor promote arterial formation at the sites of adult neoangiogenesis in mice. J Clin Invest 2008; 118: 2062–2075
   PubMed Web of Science ®Google Scholar
• Zhang HT, Scott PA, Morbidelli L, Peak S, Moore J, Turley H, et al. The 121-amino-acid isoform of vascular endothelial growth factor is more strongly tumorigenic than other splice variants in vivo. Br J Cancer 2000; 83: 63–68
   PubMed Web of Science ®Google Scholar
• Zygalaki E, Kaklamanis L, Nikolaou NI, Kyrzopoulos S, Houri M, Kyriakides Z, et al. Expression profile of total VEGF, VEGF splice variants, and VEGF receptors in the myocardium and arterial vasculature of diabetic and nondiabetic patients with coronary artery disease. Clin Biochem 2008; 41: 82–87
   Google Scholar